This fact sheet provides information on clinical trials. Our fact sheets are designed as general introductions to each subject and are intended to be concise. For specific information on a particular clinical trial and whether you might be eligible, you should contact the researchers who are running it.
What is a clinical trial?
Clinical trials are a particular type of medical research. They are a scientific way to assess the safety and effectiveness of new treatments, procedures and therapies such as new drug treatments. The new treatments are compared with existing treatments to see if they provide improved results for patients.
Are clinical trials safe?
The health professionals, scientists and medical researchers who carry out clinical trials are restricted and governed by law as to how the trials are conducted. Strict guidelines must be followed and a set of specific rules is established for each trial.
Before clinical trials commence, they must be approved by independent medical researchers and ethics committees. Extensive research is carried out in laboratories before new treatments and therapies are tested on people.
One of the main purposes of a clinical trial is to identify the possible side effects of a new treatment. Adverse side effects might only become apparent as the trial commences. To reduce the risk, very small doses are given to people receiving the treatment in the first instance.
How do I take part in a clinical trial?
If you are a patient already receiving treatment, your doctor or specialist might ask if you are interested in taking part in a clinical trial. Alternatively, you could ask your doctor or specialist about trials for which you might be suitable, enquire at your local hospital, or search online for information on taking part in clinical trials. Researchers often make information available through registers of clinical trials which you can access online.
You might need to have a health check or tests to see if you are able to take part. You will also need to sign a consent form. A key aspect of clinical trials is that participants give informed consent to take part, so you will be given specific information which describes what will happen during the trial and explains the possible risks and benefits. If you have any questions or concerns you should ask the people running the trial.
Although your consent is recorded in your medical notes, if you wish to stop taking part in a clinical trial, you can do so at any stage. You do not have to give a reason and it will not affect your right to continue receiving the standard treatment for your condition.
Are the results of clinical trials reliable?
It is important that clinical trials are conducted fairly and without bias and researchers use different methods to ensure the most reliable results. These methods include:
- comparing the results for people given the new treatment (the test group) with the results for people given the standard treatment or a placebo (the control group)
- selecting people randomly for each group (a randomised trial)
- not telling participants which group they are in (a blind trial)
- ensuring that the researchers themselves do not know which group is receiving which treatment (a double blind trial)
Researchers also involve large numbers of people in clinical trials to reduce the element of chance affecting results as it can when only small numbers of people are assessed.
What happens during clinical trials?
Clinical trials are divided into different stages.
This initial stage assesses the following:
- how much of a treatment can be given without causing adverse side effects
- what side effects the treatment causes
- whether the treatment works and affects people in the way intended
Only a small number of people, usually fewer than thirty, are required to take part in this stage of the trial. It is common for payments to be made to people participating in Phase I. Participants might be healthy volunteers or patients with a particular condition.
This stage assesses the same main areas as Phase I but on a much larger scale. Phase II might involve up to a hundred people. With the results of Phase I, the researchers will have identified the most serious side effects and they will now look more closely at safe doses and the strength of the new treatment. All participants will be patients and they will be monitored closely to identify any changes to their condition. This might involve frequent tests and investigations such as blood tests, X-rays and scans.
This stage is on a much larger scale again, involving hundreds or thousands of people from several different hospitals and often from several different countries. Phase III assesses whether the new treatments are more effective than existing treatments. It is at this stage that test groups and control groups are used to compare the effectiveness of treatments. Any side effects or impact on the participants’ quality of life are monitored closely. Phase III will only go ahead once Phases I and II have been completed and the researchers have evidence on safe doses and possible side effects.
Phase III can take a year or longer to complete. Sometimes, if Phase III of a clinical trial is scheduled to take several years to complete, researchers produce interim reports on the results as the evidence becomes available.
Monitoring successful new treatments after a clinical trial
The safety, side effects and effectiveness of new treatments will continue to be monitored closely even after they have passed a clinical trial and are licensed for use.
Will the new treatment be a success?
Patients often consider taking part in a clinical trial if their standard treatment has not been successful. In this situation, it is natural to have high hopes and expectations of new treatments. However, it is important to remain aware that the purpose of the trial is to test whether a new treatment works.
Unfortunately, there are no guarantees that it will. In many cases, clinical trials show that new treatments are not successful.
Should you wish to view the references for this publication, please contact email@example.com
This information was last checked in November 2015. Due for review in November 2018
Download this publication as:
Please note, we do not send out fact sheets; they are download only. If you do require a hard copy of this fact sheet, then please contact us.
Please tell us what you think of our information so we can keep improving it. Fill in our feedback form